Auditory brainstem implant in auditory rehabilitation of patients with neurofibromatosis type 2: Hannover programme.
An auditory brainstem implant (ABI) is indicated for patients suffering from bilateral neural deafness. The most affected patients are those with neurofibromatosis type 2 (NF2). An implantation is possible either at the same time as, or after, surgical removal of an acoustic neuroma. This paper demonstrates the results of eight out of 11 patients with NF2, seven of whom received an ABI after tumour removal. Pre-operatively, all of them were deaf. Post-operatively, the first fitting served to determine the individual stimulation parameters for each electrode. The stimulation-dependent side-effects were eliminated by reducing the stimulus intensity without causing negative effects on the hearing with the ABI. Only in one case was an open set understanding achieved within the first year. However, all patients had a better speech understanding when they combined their hearing with the ABI and their lip-reading abilities. There is no correlation between the performance with ABI and the tumour size or the duration of deafness.
Lesinski-Schiedat
A
A
ENT Clinic, Medizinische Hochschule Hannover, Germany.
Frohne
C
C
Illg
A
A
Rost
U
U
Matthies
C
C
Battmer
R D
RD
Samii
M
M
Lenarz
T
T
D000293:Adolescent; D000328:Adult; D001933:Brain Stem / Q000601:surgery*; D012048:Correction of Hearing Impairment / Q000379:methods; D006313:Hearing Loss, Central / Q000209:etiology / Q000534:rehabilitation / Q000601:surgery*; D006801:Humans; D008085:Lipreading; D016518:Neurofibromatosis 2 / Q000150:complications / Q000601:surgery*; D011183:Postoperative Complications; D019919:Prosthesis Implantation; D013067:Speech Perception; D016896:Treatment Outcome